Company Profiles

driven by the PitchBook Platform

Aprea

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

2003

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$30M

Latest Deal Amount

$34M

Total Amount Raised

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

Website:

www.aprea.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Karolinska Institutet Science Park Nobels väg 3 171 65 SolnaSweden +46 (0)8 508 84 50 4
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aprea's full profile, request a free trial.

Aprea Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aprea Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
5AM VenturesVenture CapitalMinority000 0000000 0000
btov PartnersVenture CapitalMinority000 0000000 0000
HealthCapVenture CapitalMinority000 0000000 0000
IndustrifondenVenture CapitalMinority000 0000000 0000
Karolinska DevelopmentVenture CapitalMinority000 0000000 0000
5AM Ventures Venture Capital
btov Partners Venture Capital
HealthCap Venture Capital
Industrifonden Venture Capital
Karolinska Development Venture Capital

Aprea Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Christian SchadePresident & Chief Executive Officer
Ulf BjorklundChief Executive Officer
Kimmo SinervoChief Financial Officer, Executive, Business Administration & Consultant
Lars Abrahmsen Ph.DChief Scientific Officer
Galina SelivanovaCo-Founder & Deputy Director
Christian Schade President & Chief Executive Officer
Ulf Bjorklund Chief Executive Officer
Kimmo Sinervo Chief Financial Officer, Executive, Business Administration & Consultant
Lars Abrahmsen Ph.D Chief Scientific Officer
Galina Selivanova Co-Founder & Deputy Director

Aprea Board Members (9)

NameRepresentingRoleSinceContact
Info
Bernd Seizinger Ph.DSelfExecutive Chairman000 0000
Guido Magni MDVersant VenturesPartner & Managing Director000 0000
Johan Christenson Ph.DHealthCapPartner000 0000
Jonathan Hepple Ph.DRosetta Capital(London)Partner000 0000
Klas Wiman Ph.DSelfBoard Member & Co-Founder000 0000
Bernd Seizinger Ph.D Executive Chairman Self
Guido Magni MD Partner & Managing Director Versant Ventures
Johan Christenson Ph.D Partner HealthCap
Jonathan Hepple Ph.D Partner Rosetta Capital(London)
Klas Wiman Ph.D Board Member & Co-Founder Self
Request full access to PitchBook